Rapid pain relief and marked sclerotic change of multiple bone metastases from a synovial sarcoma after treatment with intravenous pamidronate and chemotherapy

Journal of Orthopaedic Science

Volumn 14, Issue 2, 2009, Pages 224-227

  Osanai, Toshihisa ^a   Tsuchiya, Takashi ^a   Sugawara, Masato ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; CYTOKERATIN; DOXORUBICIN; EPITHELIAL MEMBRANE ANTIGEN; ETOPOSIDE; IFOSFAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OSTEOCALCIN; OXIDRONATE TECHNETIUM TC 99M; PAMIDRONIC ACID; VIMENTIN; VINCRISTINE;

ADULT; ANALGESIA; ARTICLE; BACKACHE; BONE BIOPSY; BONE METASTASIS; BONE RADIOGRAPHY; BONE SCINTISCANNING; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMUR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOLYSIS; OSTEOSCLEROSIS; PELVIS; PELVIS PAIN SYNDROME; QUADRIPLEGIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD COMPRESSION; SPINE; SPINE METASTASIS; SYNOVIAL SARCOMA;

EID: 63849134743     PISSN: 09492658     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00776-008-1300-0     Document Type: Article

References (16)

1. P.L. Jager H.J. Hoekstra J.A. Leeuw W.T. van Der Graaf E.G. de Vries D.A. Piers 2000 Routine bone scintigraphy in primary staging of soft tissue sarcoma; is it worthwhile? Cancer 89 1726 1731
2. A. Rehders S.B. Hosch P. Scheunemann N.H. Stoecklein W.T. Knoefel M. Peiper 2007 Benefit of surgical treatment of lung metastasis in soft tissue sarcoma Arch Surg 142 70 75
3. B.E. Hillner J.N. Ingle R.T. Chlebowski J. Gralow G.C. Yee N.A. Janjan 2003 American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer J Clin Oncol 21 4042 4057
4. G.N. Hortobagyi R.L. Theriault L. Porter D. Blayney A. Lipton C. Sinoff 1996 Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases; protocol 19 Aredia Breast Cancer Study Group N Engl J Med 335 1785 1791
5. F. Saad D.M. Gleason R. Murray S. Tchekmedyian P. Venner L. Lacombe 2002 A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma J Natl Cancer Inst 94 1458 1468
6. A. Lipton M. Zheng J. Seaman 2003 Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma Cancer 98 962 969
7. L.S. Rosen D. Gordon N.S. Tchekmedyian R. Yanagihara V. Hirsh M. Krzakowski 2004 Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, phase III, double-blind, placebo-controlled trial Cancer 100 2613 2621
8. T. Osanai T. Tsuchiya T. Ogino K. Nakahara 2006 Long-term prevention of skeletal complications by pamidronate in a patient with bone metastasis from endometrial carcinoma; a case report Gynecol Oncol 100 195 197
9. G. Vitale F. Fonderico A. Martignetti M. Caraglia A. Ciccarelli V. Nuzzo 2001 Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer Br J Cancer 84 1586 1590
10. J.H. Edmonson L.M. Ryan R.H. Blum J.S. Brooks M. Shiraki S. Frytak 1993 Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas J Clin Oncol 11 1269 1275
11. S. Yalçin I. Güllü I. Barişta G. Tekuzman Y. Ozişik I. Celik 1998 Treatment of advanced refractory sarcomas with ifosfamide and etoposide combination chemotherapy Cancer Invest 16 297 302
12. H. Fleisch 2002 Development of bisphosphonates Breast Cancer Res 4 30 34
13. J.F. Bukowski C.C. Dascher H. Das 2005 Alternative bisphosphonate targets and mechanisms of action Biochem Biophys Res Commun 328 746 750
14. S.J. Houston R.D. Rubens 1998 The tolerability and adverse event profile of pamidronate disodium Rev Contemp Pharmacother 9 213 224
15. C.A. Migliorati M.M. Schubert D.E. Peterson L.M. Seneda 2005 Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy Cancer 104 83 93
16. S.M. Ali F.J. Esteva G. Hortobagyi H. Harvey J. Seaman R. Knight 2001 Safety and efficacy of bisphosphonates beyond 24 months in cancer patients J Clin Oncol 19 3434 3437